Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens
- 6 October 2011
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 29 (43), 7505-7513
- https://doi.org/10.1016/j.vaccine.2011.06.121
Abstract
No abstract availableKeywords
Funding Information
- Bill and Melina Gates (OPP1008300)
- Swedish Research Council
- MSB-SIDA
This publication has 18 references indexed in Scilit:
- Establishment of an Adult Mouse Model for Direct Evaluation of the Efficacy of Vaccines against Vibrio choleraeInfection and Immunity, 2009
- Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunitVaccine, 2008
- A review of vaccine research and development: human enteric infectionsVaccine, 2006
- Lipopolysaccharides of Vibrio cholerae: III. Biological functionsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Epidemic and Endemic Cholera Trends over a 33‐Year Period in BangladeshThe Journal of Infectious Diseases, 2002
- Comparison of Vibrio cholerae Pathogenicity Islands in Sixth and Seventh Pandemic StrainsInfection and Immunity, 2001
- Safety, Immunogenicity, and Protective Efficacy of the Whole-Cell/Recombinant B Subunit (WC/rBS) Oral Cholera Vaccine Against Travelers' DiarrheaJournal of Travel Medicine, 1995
- Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccineThe Lancet, 1991
- Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field TrialThe Journal of Infectious Diseases, 1988
- Field Trial of Oral Cholera Vaccines in Bangladesh: Results of One Year of Follow-UpThe Journal of Infectious Diseases, 1988